Cholestyramine dosage and administration: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Created page with "__NOTOC__ {{Cholestyramine}} {{CMG}}; {{AE}} {{SS}} ==Dosage and Administration == <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = PREVALITE (CH...")
 
(←Redirected page to Cholestyramine)
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Cholestyramine]]
{{Cholestyramine}}
{{CMG}}; {{AE}} {{SS}}
 
==Dosage and Administration
 
==
 
<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = PREVALITE (CHOLESTYRAMINE) POWDER, FOR SUSPENSION [UPSHER-SMITH LABORATORIES INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dd434ef8-8af3-434c-a0a0-9a0b18459ba0 | publisher =  | date =  | accessdate = 10 February 2014 }}</ref>
 
 
==References==
 
{{Reflist|2}}
 
{{Lipid modifying agents}}
 
[[Category:Hepatology]]
[[Category:Bile acid sequestrants]]
[[Category:Cardiovasuclar Drugs]]
[[Category:Drugs]]

Latest revision as of 13:52, 21 July 2014

Redirect to:

Retrieved from "https://www.wikidoc.org/index.php?title=Cholestyramine_dosage_and_administration&oldid=996431"